Cargando…

Mapping clustered mutations in cancer reveals APOBEC3 mutagenesis of ecDNA

Clustered somatic mutations are common in cancer genomes and previous analyses reveal several types of clustered single-base substitutions, which include doublet- and multi-base substitutions(1–5), diffuse hypermutation termed omikli(6), and longer strand-coordinated events termed kataegis(3,7–9). H...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bergstrom, Erik N., Luebeck, Jens, Petljak, Mia, Khandekar, Azhar, Barnes, Mark, Zhang, Tongwu, Steele, Christopher D., Pillay, Nischalan, Landi, Maria Teresa, Bafna, Vineet, Mischel, Paul S., Harris, Reuben S., Alexandrov, Ludmil B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8850194/ https://www.ncbi.nlm.nih.gov/pubmed/35140399 http://dx.doi.org/10.1038/s41586-022-04398-6

Ejemplares similares

Transcriptional immune suppression and upregulation of double stranded DNA damage and repair repertoires in ecDNA-containing tumors
por: Lin, Miin S., et al.
Publicado: (2023)

Mechanisms of APOBEC3 mutagenesis in human cancer cells
por: Petljak, Mia, et al.
Publicado: (2022)

Extrachromosomal DNA (ecDNA): an origin of tumor heterogeneity, genomic remodeling, and drug resistance
por: Pecorino, Lauren T., et al.
Publicado: (2022)

MEDB-33. The landscape of ecDNA in medulloblastoma
por: Chapman, Owen, et al.
Publicado: (2022)

EcSeg: Semantic Segmentation of Metaphase Images Containing Extrachromosomal DNA
por: Rajkumar, Utkrisht, et al.
Publicado: (2019)

Visualizing and exploring patterns of large mutational events with SigProfilerMatrixGenerator
por: Khandekar, Azhar, et al.
Publicado: (2023)

Chromatin-associated RNA Dictates the ecDNA Interactome in the Nucleus
por: Liang, Zhengyu, et al.
Publicado: (2023)

Extrachromosomal DNA (ecDNA) in cancer: mechanisms, functions, and clinical implications
por: Dong, Yucheng, et al.
Publicado: (2023)

An overview of mutational and copy number signatures in human cancer
por: Steele, Christopher D, et al.
Publicado: (2022)

ecDNA within tumors: a new mechanism that drives tumor heterogeneity and drug resistance
por: Zeng, Xixi, et al.
Publicado: (2020)

Pioneering insights of extrachromosomal DNA (ecDNA) generation, action and its implications for cancer therapy
por: Li, Zesheng, et al.
Publicado: (2022)

Extrachromosomal DNA (ecDNA): Unveiling its role in cancer progression and implications for early detection
por: Wu, Shuhong, et al.
Publicado: (2023)

APOBEC3B regulates R-loops and promotes transcription-associated mutagenesis in cancer
por: McCann, Jennifer L., et al.
Publicado: (2023)

Association of a germline copy number polymorphism of APOBEC3A and APOBEC3B with burden of putative APOBEC-dependent mutations in breast cancer
por: Nik-Zainal, Serena, et al.
Publicado: (2014)

Characterizing Mutational Signatures in Human Cancer Cell Lines Reveals Episodic APOBEC Mutagenesis
por: Petljak, Mia, et al.
Publicado: (2019)

ATACAmp: a tool for detecting ecDNA/HSRs from bulk and single-cell ATAC-seq data
por: Cheng, Hansen, et al.
Publicado: (2023)

Phase separation of ecDNA aggregates establishes in-trans contact domains boosting selective MYC regulatory interactions
por: Conte, Mattia, et al.
Publicado: (2023)

ViFi: accurate detection of viral integration and mRNA fusion reveals indiscriminate and unregulated transcription in proximal genomic regions in cervical cancer
por: Nguyen, Nam-phuong D, et al.
Publicado: (2018)

Advances in sequencing-based studies of microDNA and ecDNA: Databases, identification methods, and integration with single-cell analysis
por: Jiang, Rong, et al.
Publicado: (2023)

HPV integration generates a cellular super-enhancer which functions as ecDNA to regulate genome-wide transcription
por: Tian, Rui, et al.
Publicado: (2023)

Novel insights into the ecDNA formation mechanism involving MSH3 in methotrexate-resistant human colorectal cancer cells
por: Wang, Xu, et al.
Publicado: (2023)

Molecular mechanism and clinical impact of APOBEC3B-catalyzed mutagenesis in breast cancer
por: Harris, Reuben S
Publicado: (2015)

Single‐cell third‐generation sequencing‐based multi‐omics uncovers gene expression changes governed by ecDNA and structural variants in cancer cells
por: Chang, Lei, et al.
Publicado: (2023)

Genetic inhibitors of APOBEC3B-induced mutagenesis
por: Mertz, Tony M., et al.
Publicado: (2023)

FaNDOM: Fast nested distance-based seeding of optical maps
por: Raeisi Dehkordi, Siavash, et al.
Publicado: (2021)

DNA replication stress mediates APOBEC3 family mutagenesis in breast cancer
por: Kanu, Nnennaya, et al.
Publicado: (2016)

FHIT loss-induced DNA damage creates optimal APOBEC substrates: Insights into APOBEC-mediated mutagenesis
por: Waters, Catherine E., et al.
Publicado: (2014)

Structural basis for targeted DNA cytosine deamination and mutagenesis by APOBEC3A and APOBEC3B
por: Shi, K., et al.
Publicado: (2016)

Exploring the landscape of focal amplifications in cancer using AmpliconArchitect
por: Deshpande, Viraj, et al.
Publicado: (2019)

An APOBEC3A hypermutation signature is distinguishable from the signature of background mutagenesis by APOBEC3B in human cancers
por: Chan, Kin, et al.
Publicado: (2015)

APOBEC-related mutagenesis and neo-peptide hydrophobicity: implications for response to immunotherapy
por: Boichard, Amélie, et al.
Publicado: (2018)

PrimPol prevents APOBEC/AID family mediated DNA mutagenesis
por: Pilzecker, Bas, et al.
Publicado: (2016)

APOBEC3B, a molecular driver of mutagenesis in human cancers
por: Zou, Jun, et al.
Publicado: (2017)

APOBEC mutagenesis is low in most types of non-B DNA structures
por: Ponomarev, Gennady V., et al.
Publicado: (2022)

APOBEC mutagenesis is a common process in normal human small intestine
por: Wang, Yichen, et al.
Publicado: (2023)

Uncovering novel mutational signatures by de novo extraction with SigProfilerExtractor
por: Islam, S.M. Ashiqul, et al.
Publicado: (2022)

The DNA cytosine deaminase APOBEC3H haplotype I likely contributes to breast and lung cancer mutagenesis
por: Starrett, Gabriel J., et al.
Publicado: (2016)

Perspective: APOBEC mutagenesis in drug resistance and immune escape in HIV and cancer evolution
por: Venkatesan, S, et al.
Publicado: (2018)

Potential Utilization of APOBEC3-Mediated Mutagenesis for an HIV-1 Functional Cure
por: Ikeda, Terumasa, et al.
Publicado: (2021)

Prospectively defined patterns of APOBEC3A mutagenesis are prevalent in human cancers
por: DeWeerd, Rachel A., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tr12m78e6otv3c29kkov2j9k5p